|
|
Genopole Industries, 4 rue Pierre Fontaine
Evry, 91000 France
phone:(33) (0) 1 60 87 89 00
fax:(33) (0) 1 60 87 89 99
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.obetherapy.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Drugs for obesity, hypercholesterolemia and type II diabetes. |
|
| Management |
| Itzik HAROSH, PhD, Chairman and Chief Scientist Officer (CSO); Sandrine BRAUD, PhD, COO & Scientific Director; Vladimir CHARRON, Engineer; Pr. Marco A. Ciufolini, PhD, Advisor in Medicinal Chemistry
|
| |
|
|
| |
|
| Keywords |
| biotech, targets, drugs, obesity, hypercholesterolemia, Diabetes, blood sugar, diabetic, metabolic, insulin, intestine, absorption, polymorphism, genes, phenotype |
|
|
|
| Description |
|
ObeTherapy is dedicated to the discovery of new targets and the development of new drugs for obesity, hypercholesterolemia and type II diabetes. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members